Lundgren D L, Haley P J, Hahn F F, Diel J H, Griffith W C, Scott B R
Inhalation Toxicology Research Institute, Lovelace Biomedical and Environmental Research Institute, Albuquerque, New Mexico 87185.
Radiat Res. 1995 Apr;142(1):39-53.
To study the long-term biological effects of repeated inhalation exposure to 239PuO2, 84-day-old rats were exposed to aerosols of 239PuO2 to re-establish desired 239Pu lung burdens of 26, 80 or 250 Bq every other month for 1 year (seven exposures). Other rats were exposed once at 84 or 450 days of age to achieve desired initial lung burdens of 30, 90, 280 or 850 Bq. The incidences of lung tumors were not significantly different (Fisher's exact test; P > 0.05) in groups of rats with similar lifetime mean alpha-particle doses to the lungs of 0.90 +/- 0.39 to 4.4 +/- 1.8 (+/- SD) Gy, whether exposed once or repeatedly. Among rats with mean alpha-particle doses of 12 +/- 2.4 to 10 +/- 2.1 Gy to the lungs after single or repeated exposures, respectively, the crude incidence of lung tumors was significantly less (Fisher's exact test; P < 0.05) in the rats exposed repeatedly. Times to death of rats with lung tumors were compared among groups with similar alpha-particle doses to the lungs after single or repeated exposure to 239PuO2. Those that died with lung tumors after repeated exposures died at times similar to (Mantel-Cox statistic; P > 0.05) or later than (Mantel-Cox statistic; P < 0.05) those for 84-day-old rats exposed once. The risk of lung tumors in rats per unit dose to the lungs was less in the rats exposed repeatedly than in those exposed once. It was concluded that alpha-particle doses to the lung of rats exposed repeatedly to aerosols of 239PuO2 were not more carcinogenic and possibly were less carcinogenic than the dose after a single inhalation exposure when rats with similar lifetime alpha-particle doses to the lungs were compared. The relative biological effectiveness in rats of the alpha-particle dose to the lungs from inhaled 239PuO2 relative to beta-particle doses to the lungs from inhaled 144CeO2 was 21 +/- 3.
为研究反复吸入暴露于239PuO2的长期生物学效应,84日龄大鼠每隔一个月暴露于239PuO2气溶胶中,持续1年(共7次暴露),以重新建立26、80或250 Bq的预期239Pu肺负荷。其他大鼠在84日龄或450日龄时暴露一次,以达到30、90、280或850 Bq的预期初始肺负荷。在终生平均α粒子肺部剂量相似(0.90±0.39至4.4±1.8(±标准差)Gy)的大鼠组中,无论单次暴露还是反复暴露,肺肿瘤的发生率均无显著差异(Fisher精确检验;P>0.05)。在单次或反复暴露后,肺部平均α粒子剂量分别为12±2.4至10±2.1 Gy的大鼠中,反复暴露的大鼠肺部肿瘤的粗发病率显著较低(Fisher精确检验;P<0.05)。比较单次或反复暴露于239PuO2后肺部α粒子剂量相似的各组中患有肺肿瘤大鼠的死亡时间。反复暴露后死于肺肿瘤的大鼠的死亡时间与单次暴露的84日龄大鼠相似(Mantel-Cox统计量;P>0.05)或更晚(Mantel-Cox统计量;P<0.05)。反复暴露的大鼠每单位肺部剂量的肺肿瘤风险低于单次暴露的大鼠。得出的结论是,当比较终生肺部α粒子剂量相似的大鼠时,反复暴露于239PuO2气溶胶的大鼠肺部的α粒子剂量致癌性并不更高,甚至可能低于单次吸入暴露后的剂量。吸入239PuO2产生的α粒子肺部剂量相对于吸入144CeO2产生的β粒子肺部剂量在大鼠中的相对生物学效能为21±3。